OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2022-04-30-accounts

REGISTERED COMPANY NUMBER: 02854091 (England and Wales) REGISTERED CHARITY NUMBER: 1029318

REPORT OF THE TRUSTEES AND AUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 APRIL 2022

FOR

TAMESIDE & GLOSSOP HOSPICE LIMITED (A COMPANY LIMITED BY GUARANTEE)

Moss & Williamson Limited Chartered Accountants Statutory Auditor Booth Street Chambers Ashton-under-Lyne Lancashire OL6 7LQ

TAMESIDE & GLOSSOP HOSPICE LIMITED

CONTENTS OF THE FINANCIAL STATEMENTS for the Year Ended 30 April 2022

Page
Report of the Trustees 1 to 15
Report of the Independent Auditors 16 to 18
Statement of Financial Activities 19
Consolidated Balance Sheet 20
Company Balance Sheet 21
Cash Flow Statement 22
Notes to the Cash Flow Statement 23
Notes to the Financial Statements 24 to 38
Detailed Statement of Financial Activities 39 to 41

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT)

for the Year Ended 30 April 2022

The trustees, who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 30 April 2022. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).

REFERENCE AND ADMINISTRATIVE INFORMATION

GOVERNING INSTRUMENT

Memorandum and Articles of Association (Company limited by guarantee)

REGISTERED CHARITY NUMBER

1029318

PATRONS

Tony Husband Justin Moorhouse Martin Wilde Julie Hesmondhalgh Sharman Birtles MBE Philip Cowper Julie Goodyear MBE Brian Wild

PRESIDENT

Martin J. Willescroft

PRINCIPAL OFFICERS

Chair: Vice Chairman: Chief Executive: Medical Director: Director of Clinical Services/Registered Manager: Head of Finance:

Philip Millson Mark Llewellin Karen Houlston MA Dr Neil Pender Nicola Cheetham Ian Wicks FCCA

Executive Team (Non-Director/Trustees)

Karen Houlston MA FMAAT Nicola Cheetham Dr Neil Pender Ian D Wicks FCCA

Page 1

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT) for the Year Ended 30 April 2022

COUNCIL

Incorporating Director/Trustees

Martin J. Willescroft John H. Maltby LLB Brian Wild (Resigned 7[th] December 2021) Stephen Flanagan Elizabeth Needham Philip J Millson Timothy Jackson Mark Llewellin Paul Schofield (Appointed 22[nd] June 2021) Joanne Ormston (Appointed 17[th] August 2021) Rachel Freeman (Appointed 17[th ] August 2021)

PRINCIPAL ADDRESS & REGISTERED OFFICE

Willow Wood Close Off Mellor Road Ashton-under-Lyne Lancashire OL6 6SL

AUDITORS

Moss & Williamson Limited Booth Street Chambers 32, Booth Street Ashton-under-Lyne Lancashire OL6 7LQ

SOLICITORS

Thompson & Cooke 12 Stamford Street Stalybridge Cheshire SK15 1LA

PRINCIPAL BANKERS & INVESTMENT MANAGERS

Investec Wealth & Investment Ltd 2[nd] Floor, 3 Hardman Street Spinningfields Manchester M3 3HF

NatWest Bank PLC Warrington Street Ashton-Under-Lyne Lancashire OL6 6JL

Page 2

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT) for the Year Ended 30 April 2022

We are pleased to present our report and the audited financial statements of the company Tameside & Glossop Hospice Limited (known throughout the region as Willow Wood Hospice) for the year ended 30 April 2022.

The year continued to be a difficult one due to the continuing effects of the Coronavirus pandemic. We are grateful to everyone for all their continued support throughout this time, at the outset no one anticipated the time scale of the Pandemic. Whilst all our activities within the Hospice were affected and services reduced or unable to happen throughout that time and beyond, we were truly amazed at the way in which everyone worked together to ensure the Hospice continued to operate its services by adapting and embracing new technology and finding different ways of working to ensure that we were able to reach more patients in the community that more than ever needed our support.

As we recover from the Pandemic and reviewing the services affected, it has given us a great opportunity to assess, refocus and make improvements, but our main focus will always be meeting the needs of our community.

Each year the Hospice receives funding from the Government through our local Clinical Commissioning Group (now Integrated Care Board). We need to raise £3.35M this year to continue to provide the Care and Support to our patients, their families and carers. The CCG contribute about 19% of this. Like many charities in the pandemic we needed to respond to the financial crisis, navigating through several lockdowns at a time when fundraising was the most difficult in all our years of operation. We were grateful that the government recognised the important role that Hospices play and as an essential service, emergency funding was provided through Hospice UK to enable those services to continue. Without government support we would have experienced a huge deficit.

That funding has now come to an end and whilst we are working towards reshaping our fundraising events and looking to focus on new ways of increasing our income, we are forecasting a deficit budget for the coming year and beyond which will impact on our reserves.

CHARITABLE PURPOSE

Willow Wood Hospice is an independent, charitable voluntary body, funded mainly by the generosity of our local community and an annual grant from the Tameside & Glossop Clinical Commissioning Group. Willow Wood opened its doors in 1999. The Hospice places great value on its connections and working relationships with our local NHS foundation trust and local businesses.

Our driving force is that a Hospice is not just a building but a whole philosophy incorporating care, love and understanding for patients and their carers. This enables the patient to achieve the best quality of life appropriate to their individual needs and wishes throughout the changing phases of their illness, whilst acknowledging and responding to the needs of the families and carers. We aim to provide high quality care ensuring comfort and personal dignity at all times.

Our Vision

We aim to continue to be a leader in the development of Hospice and Palliative care, providing excellence in quality care for people with life limiting illnesses, putting our patients and families at the heart of everything we do for the c.255,000 people of Tameside & Glossop.

Our Mission

Our Mission is to continue to provide, free of charge, the highest quality supportive and end of life care to patients with life limiting illnesses, along with support to the families and carers during illness and continuing after bereavement. The hospice has a multi-disciplinary approach to care and incorporates the input of the medical and nursing teams along with allied health care professionals such as physiotherapy and occupational therapy, as well as the family support team.

Page 3

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT) for the Year Ended 30 April 2022

Our Values

Our values form the core success of our operation and are integral to our everyday work.

We could never have predicted the Pandemic or the challenges the Hospice would face. Whilst our plans were affected, we continued, where possible to meet our strategic objectives.

OBJECTIVES AND ACTIVITIES

Strategic Objectives:

  1. Continue to be the main provider of Hospice care, support and education in palliative care throughout Tameside and Glossop.

  2. Promote and widen the services that we offer from Willow Wood Hospice, collaboratively working with other stakeholders as Tameside and Glossop undergoes transformation in line with patient and carer needs.

  3. Raise awareness of Willow Wood Hospice within the Tameside and Glossop communities and within the wider Greater Manchester networks.

  4. Assess and increase the retail portfolio to ensure the continued growth of income from retail activities (carried out via our Subsidiary).

  5. Refresh fundraising campaigns to ensure the generation of sufficient income to match the future demands of our expanding services.

  7. Maintain a robust finance, investment and expenditure process.

  8. Attract, develop, retain, support and reward our paid staff and volunteers to ensure a workforce fit to deliver hospice goals.

Page 4

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT) for the Year Ended 30 April 2022

Activities

Willow Wood Hospice provides services free of charge to adults with life Limiting illnesses within the Tameside & Glossop region. Our services are available to all groups within the communities we serve and these include:

In-Patient Unit

Accommodation for 12 patients is by way of 10 en-suite bedrooms, 8 single and 2 double. We care for patients for symptom control management and end of life care. Care is provided for the patients, their families and carers by our team of nurses, doctors, physiotherapists, occupational therapist, pre and post bereavement counselling, support and chaplaincy.

Day Services

Our Day Services are delivered in our Day Services lounge and associated clinic spaces. All patients are supported through a nursing assessment and then have access to our group and individual therapies. Available group and therapy support include:

All these services available in a welcoming lounge and beautiful gardens. They are designed to enhance wellbeing, improve physical function and offer emotional support. Medical support is available as required.

Patients can be referred through a health care professional or self-refer.

Physiotherapy/Occupational Therapy

The benefits of physiotherapy and occupational therapy are to maintain function at every stage of the disease. Our aim is to help people manage their symptoms, maintain independence and improve quality of life. These services also help people at early stages of their illness to enable rehabilitation as they go through treatments, aiming to maximise their health and wellbeing. We offer assessment in patients own home environment as required.

Complementary therapies

Complementary therapies at Willow Wood include aromatherapy, massage, reflexology, reiki and relaxation and are offered alongside conventional treatment. The service is for both day and inpatients with an outpatient’s facility. The benefits include relaxation, balance and a feeling of well-being which can in turn help to optimise the person’s quality of life.

Dementia Service

Treatment of end of life care for dementia patients can be distressing and stressful for the patient, family and carers and frequent transfer to acute hospital for treatment of recurrent infections or dehydration may prove traumatic for those patients in the advanced stage of dementia. Willow Wood engaged a dedicated specialist service to provide advice and support to families, carers and health care professionals.

Page 5

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT) for the Year Ended 30 April 2022

Advance care planning is the central core of this dementia service enabling patients to continue to be cared for in their usual place of residence and reduce the need for hospital admissions.

We operate a Dementia Café to support those living with Dementia and their carers. We also offer rolling programmes of support for carers. The support offered alleviates fears, educates and empowers carers and also offers and shares support and understanding through peer support.

Family support services

Chaplaincy - A part time Chaplain who is assisted by a voluntary chaplaincy team offering multi faith pastoral care to patients, carers, family, staff and volunteers.

Bereavement Counsellor - We have bereavement counsellors who can offer pre or post 1-1 or group support to bereaved relatives/carers and young people of patients of Willow Wood. Providing a confidential space for the bereaved to explore and make sense of the painful process of grief in an environment that enables the expression of complex thoughts, feelings and experiences without judgement.

DELIVERING PUBLIC BENEFIT

Willow Wood Hospice provides, free of charge, the highest quality supportive and end of life care to patients with life limiting illnesses with the aim to help each individual attain the best quality of life (regardless of race, colour or religion) by providing the highest standard of holistic care in a warm, friendly environment. The care offered also extends to patient families and carers during illness and continuing after bereavement. Willow Wood Hospice is regulated by the Care Quality Commission (CQC), the independent regulator of health and social care in England.

A worthwhile indication of public benefit activities can be seen through the following review of our achievements and performance. There is also further evidence by the response we receive from the community of Tameside and Glossop that we serve. In the 25 years since the Hospice appeal was launched, we have become established as a valuable and important part of the community and we receive hundreds of comments and letters of thanks. We embrace feedback in any way and we continually use this information to improve quality in all areas of the service we provide.

We continue to improve and grow through continually assessing the needs of our community and working proactively in ensuring that our services are in-line with both community and government recommendations. Working closely with other local service providers we undertake projects that not only help us provide the best end of life care for patients and their families but that help reduce the burden on the NHS.

Hospices throughout the UK are already leading a range of initiatives that seek, to either prevent avoidable admission to hospital for people approaching the end of life, or facilitate the appropriate and timely transfer of hospital patients who have no clinical need or wish to be in a hospital bed at the end of life.

We have referred to the guidance contained in the Charity Commission’s general guidance on public benefit when reviewing our aims and objectives and in planning our future activities.

Page 6

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT) for the Year Ended 30 April 2022

STRATEGIC REPORT

ACHIEVEMENTS AND PERFORMANCE 2021/2022

Patient Care and Services

Willow Wood Hospice are widely recognised by the healthcare stakeholders and the community we serve as the leader in palliative care in the community. We continue to deliver a range of services to support patients, their families and carers and are continually looking to develop other services in order to enhance our care to the community.

Throughout the year of operation, despite the challenges faced from the pandemic, the Hospice was able to continue to offer adult and children one-to-one counselling, albeit in a safe and appropriate way to the service user. This has now resumed to face to face.

With Day Service activities suspended, the team remained in contact with patients by telephone before they started to provide patients with support in their own homes and as we settle back to resuming normal activities this service has continued with the introduction of Communities and Therapies Services (CaTs).

The Dementia Specialist nurses continued to offer their services, advice and support to those referred, both in private homes and care homes. Like most The Dementia Café to support those living with Dementia and their carers was suspended in the Pandemic, this has now been resumed. However, we maintained the offer rolling programmes of support for carers. The support offered alleviates fears, educates and empowers carers and also offers and shares support and understanding through peer support.

Quality and Governance

Our Clinical Governance Committee is a subcommittee of the Board of Trustees and is chaired by one of our trustees. The aim of the Clinical Governance Committee is to provide assurance to the Board of Trustees that services are safe, effective, well led, responsive and caring. Driving Clinical Strategy and patient’s safety, alongside the sustainability, accessibility and regulated requirement of Clinical Services. The committees discuss, reviews and challenges the operational delivery of services and provides direction and governance assurance.

Working closely with and as a member of the Clinical Governance Committee the Clinical Director and Medical Director chair and attend two operational committees that feed into the Clinical Governance committee. The Multi Professional Clinical Leadership Meeting and the Clinical Quality and Standards Meeting.

These meetings ensure quality and safety is managed and standards met. Reporting into the group, members discuss areas including, incident and risk, monitoring and audit, medicines management, infection control, falls and pressure area care, compliments and complaints and drive actions to continuously learn and enhance the patient/carer and staff experience.

Education

E-learning for mandatory training for all our staff is managed to ensure statutory compliance. Whilst staff are also encouraged to attend appropriate developmental learning in line with their appraisal and PDP needs, such as management and leadership courses, this has continued on line in the pandemic. Staff are also supported through monthly 1-1’s with their team leaders.

Through formal agreement with external leaning institutes such as local universities, Willow Wood provides a learning opportunity, through mentoring and training to student nurses, medical students, student occupational therapists, physiotherapists, student counsellors and doctors. Qualified nurses undertake further training and development in areas relevant to their job and role.

Page 7

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT) for the Year Ended 30 April 2022

Stakeholders

Willow Wood Hospice continued throughout the year to work with the Tameside Clinical Commissioning Group and Tameside & Glossop Integrated Care NHS Foundation Trust. As the model of integrated care develops locally, working with other stakeholders in the community and hospital, Willow Wood Hospice is working to strengthen its position as a respected provider of palliative care treatment and advice. The Trust Specialist Palliative Care and Respite team are now co-located within the Hospice as we continue to develop working relationships.

Staffing

The Hospice employs a diverse and immensely skilled workforce that we need to retain and support through development and commitment to them. Many of our staff throughout the pandemic were furloughed with the exception of our clinical, medical, catering, housekeeping and senior teams. All teams have now returned and our dedicated workforce continue in their loyal support of the Hospice.

Bi-annual staff surveys with in between ‘temperature checks’ will allow us to gather insight into what is important to our employees, measure their engagement, allow them to feel their opinions are valued and identify any early warning signs that issues may arise from. This will also be benchmarked with industryspecific data.

Income Generation

With only approximately 21% of our funding being received from our local clinical commissioning group, Income Generation is an essential part of the work we do at the Hospice to ensure we can continue to provide our services free of charge. The Hospice is grateful for the support of everyone who raise funds on our behalf. Trustees have the ultimately responsibility for our income generation and fundraising activities and so review and approve the strategy budgets each year.

Fundraising

Fundraising was affected greatly during the pandemic and whilst this is slowly resuming, nationally, there have been significant changes to the way in which fundraising takes place. Mass participation events are poorly attended/supported and we are looking towards corporate support, challenge events, public external events, grants, legacy fundraising, online donation platforms, campaigns and in-memory giving to generate income.

Willow Wood Hospice is a well-known and highly respected charity and our retail outlets receive large volumes of donations from the public, our local community and beyond. Having retail outlets in our communities promotes and raises awareness of the Hospice and we are always looking to expand on our portfolio. Our shops however were closed throughout the pandemic including part of this financial year. The Hospice was however protected from this loss of income through our insurance company throughout this time. This provided income replacement over the two financial years of £324,737.

The Hospice owns a distribution warehouse which operates as a storage facility to ease the burden on the retail outlets, it also houses our substantial internet-based sales operation via eBay and other online portals. A large ground floor retail sales area is now in operation allowing us the opportunity to increase income by offering regular clearance sales. There is also a sorting area for goods and a testing area for electrical items, which are then distributed to individual shops. Another benefit is we are able to store and distribute our selection of seasonal merchandise from here as well as offering storage space for the rest of the organisation

Page 8

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT) for the Year Ended 30 April 2022

Lottery

Our Hospice Lottery whilst able to continue and grow during COVID with our lottery staff working from home this has now steadied at just over 10,000 members playing each week.

The lottery income is supported each year by two annual raffle draws.

Volunteers

The largest workforce throughout Willow Wood is our dedicated volunteers who play a vital role in the dayto-day operations of the Hospice work including its lottery and retail operations. It is recognised that the partnership we have with volunteers is vital to the success of the Hospice and without whom we would not function.

During COVID we were unable to have any volunteers working at the Hospice. The pandemic has a big impact on many of our volunteers returning and whilst we are not back to pre-pandemic numbers we still have a staggering 470 active volunteer saving the Hospice £1M per year in salaries. As with our staff, volunteers have an equally diverse range of skills. Trustees are committed in ensuring that those skills are utilised to the benefit of the Hospice and to the individual.

Our last bi-annual volunteer survey was in 2019 to establish areas for improvement in the Hospice’s management, support and dedication to our volunteers. The survey will be repeated in 2023 when we hope most of our volunteers will be re-established in their roles and new volunteers will have joined us.

Page 9

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT) for the Year Ended 30 April 2022

FINANCIAL REVIEW

The accounts for the year have been prepared in accordance with the Statement of Recommended Practice – ‘Accounting and Reporting by Charities’ SORP 2019 and complies with all statutory requirements and the governing document of the Hospice. The company meets the definition of a medium sized company and so we have adopted FRS 102 when preparing the accounts.

The SOFA is on page 19 of these financial statements. The Group has made an Operating Surplus in the year (before unrealised gains/losses on Investments) of £365,710 (2021 surplus £623,726).

After adjusting for Unrealised gains/losses on Investments, the Surplus for the year was £214,314 (2021 £943,584). This year income for the Consolidated Company is similar in level to the previous year despite the Levels of Covid Grants received from NHS England to assist us during the Covid outbreak being lower than the previous year. The NHS England Grant Income was again distributed via Hospice UK and has again been invaluable with the ability to run fundraising events not able to recommence until later in the year. The Deed of Covenant transfer this year from our Trading Subsiding Willow Wood Hospice Promotions Limited (WWHP) was also up at £607,252 (2021 £559,135). The surplus from WWHP was achieved by a combination of a near full years trading and a final Insurance Claim re the Covid closures of nearly £195,000. The results are a testament to the generosity of our supporters and the people of Tameside and Glossop.

Within the Hospice (TGH) overall income was virtually the same as the previous year despite the reduction in NHS England support grants during the year. This was mainly due to increased Legacy income and the large increase in Shop gift aid sale (and resultant Gift Aid claim) following the recommencement of shop trading in the year. The Grant income decreases have come mainly due to a fall in the NHS England grant, this was made available to allow Hospices to make Bed capacity available and provide community Support during the Covid 19 situation, the Covid pressures this year were diminished hence the reduction in funding this year £237,145 (2021: £566,065). In addition to the NHS England Grants there were a further £84,966 (2021: £62,809) in restricted fund Grants.

During this financial year, we have received a small decrease in the funding from Tameside and Glossop Clinical Commissioning Group (CCG), for the year to 30 April 2022 we received £612,077 (2021: £630,583). The CCG grant for 2020/21 included an additional £25,000, being the second half of the reduction of £50,000 requested by the CCG in 2018/19. This CCG Grant is the only regular public funding received by the Hospice towards its medical and running costs and this now represents 21.56% (2021: 23.57%) of Hospice Expenditure. The percentage has gone down this year due to the increases in some of our costs due to the reopening of the Hospice following the Covid restrictions.

The grant income together with the net income (Deed of Covenant) from our Trading Subsidiary, WWHP, this financial year accounts for 43.10% (2021: 45.32%) of the Hospice and Fundraising Expenditure. The decrease is mainly due to an increase in costs this year but has been partially offset by a higher covenanted transfer from WWHP helped by the Covid insurance claim.

Total expenditure during the financial year was £2,838,695 (2021: £2,570,826) including restricted expenditure. This increase in the year is mainly due to increased Salary and operating expenditure incurred on the reopening of Hospice services following the lifting of many of the Covid restrictions limiting a number of activities in the previous year. There were notable increases in expenditure relating to catering costs, Repairs & Maintenance, Insurances and Rental property costs due to a refurbishment. It is difficult to compare a number of the other lines of expenditure again due to Covid restrictions limiting a number of activities.

Page 10

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT) for the Year Ended 30 April 2022

RESERVES POLICY

As an organisation, we are aware that as more people live longer it is likely they will experience multiple complex health needs and that there will be a significant and steady increase in the growth in demand for both palliative and end of life care. Willow Wood Hospice has an essential role to play in meeting this demand and we need to ensure that we have the resources in place to facilitate this.

With our high dependency on voluntary donations and legacies, the Trustees consider it essential to have reserves. The aim is to hold at least twelve months running costs in General Unrestricted Reserves. At the balance sheet date, goal has been more than met in respect to Unrestricted Funds as compared to Unrestricted Expenditure.

However, we should differentiate between Free Reserves and Total General Reserves. General Unrestricted funds at the Balance Sheet date were £4,150,731 (2021: £3,933,425) or 17.5 months (2021: 18 months) of Current Year Expenditure (excluding Trading and Lottery expenditure). This decrease has been brought about due to the increase in costs during the year despite the surplus added to the reserves this year. If we look at Cash and other liquid assets, (Free Reserves), as distinct to total Unrestricted Reserves which include Fixed Assets and Investment properties, these stood at the Balance Sheet date at £2,996,981 (2021: £2,958,823). Of this amount £953,188 (2021: £947,732) have already been designated by the Trustees leaving a balance of £2,043,793 (2021: £2,011,091). These amounts represent 8.64 months (2021: 9.39 months) of Hospice Expenditure (excluding Trading and Lottery expenditure). In addition to the General Reserve an Asset Replacement Reserve is maintained as detailed in Note 1 and a schedule of work to the Hospice is currently being assessed and these reserves are being reviewed in the current year in light of this.

As stated above Tameside & Glossop Hospice draws the bulk of its income from the public with only 19.10% (2021: 18.97%) of company General Income coming by way of the annual CCG grant. This is distorted by the receipt of NHS England funding during the year. The uncertainty attached to the various income streams, particularly in terms of legacies, donations and fundraising events, necessitates that we hold substantial reserves. In light of the current turbulent economic situation brought about by the continuing Covid 19 restrictions, the war in Ukraine, rising Electricity and Gas prices, cost of living uncertainties and the impact on people’s willingness to shop and participate in events, means we are only able to state that at present the short-term situation is assured. The medium to long term must await events outside our control in respect the impact that any Climate Change restriction and the ongoing Brexit transition period may have on the financial situation of the country and Hospice.

ASSET REPLACEMENT RESERVE

The 2011 asset replacement provision totalled £437,001. Following a review of the basis of the provision after the completion of the new Hospice wing and refurbishment of the existing building, the total provision did not materially differ to this amount at the time. The Trustees decided therefore that no major adjustments were necessary. Following the replacement of many of our assets, the provision has been enhanced this year by a further £5,000 and at the yearend stood at £497,000. The current year movement on the provision is included within the transfer between funds in note 20.

Page 11

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT) for the Year Ended 30 April 2022

INVESTMENT POLICY

The investment policy is reviewed periodically through the Investment/Finance sub-committee and any amendments would be submitted to the Board for approval. It is the charities policy to specifically exclude investing directly in tobacco manufacturing companies and any decisions regarding investment are undertaken after taking appropriate advice from professional advisers. No changes were made to the Policy during the Financial Year.

This year we have continued with our policy of concentrating any new investments in Fixed Interest Deposits with major financial institutions due to continued market uncertainties. However, Willow Wood continues to invest a proportion of its funds in Equities managed externally by professional fund managers. No new money was invested in the Equity portfolio during the year however all dividends and interest received on the portfolio and any Gains on disposals are used to settle Management fees and the balance is reinvested in new Equity investments. The book cost of investments as at the yearend was £1,732,081 (2021: £1,647,922). Compared with this the market value at the yearend date stood at £1,916,942 (2021: £1,984,986). For the latest Investment sub-committee meeting the value of the portfolio stood at £1,754,713 (valued on the 31st October 2022).

FUTURE PLANS

The impact of Covid affected our business plan. As we recover from the pandemic is is vital that we refocus and a new strategic business plan is being developed for 2023 which will form the basis of future operations. However, during the interim period, the following seven main objectives have been monitored by the Trustees and Senior Management team.

  1. Continue to be the main provider of specialist care services in Tameside and Glossop: by constantly monitoring our services, seeking and acting on feedback and by advising, supporting and working with other healthcare providers. Share our expertise and learn with other healthcare providers and the wider community to ensure our people have the necessary knowledge and skills to care for patients with life limiting illnesses.

  2. Promote and widen the services that we offer from Willow Wood Hospice working collaboratively with other stakeholders: identify and expand our services in line with both patient and carer needs, assessing the feasibility of Hospice 7-day admissions. Review the accessibility of our specialist services, including BME, LGBT and minority groups.

  3. Continue to Raise awareness of Willow Wood Hospice within the Tameside and Glossop communities and within the wider Greater Manchester Networks: Keep ahead of competitors by evaluating the Hospice brand, including the logo, standardizing branding and ensuring that the image of the Hospice is ‘up to date’ and reflects what our modern hospice advocates. Promote the services of Willow Wood within the community and the wider Greater Manchester networks.

  4. Assess and increase the retail portfolio to ensure the continued growth of income from retail activities: Continually research potential properties in our community in order to develop and grow our retail activity, including the generation of further ‘department’ stores and coffee shops. Standardize the Willow Wood brand to keep ahead of competition and explore diversification of all our retail division creating a wider range of income initiatives

Page 12

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT) for the Year Ended 30 April 2022

  1. Develop and Refresh fundraising campaigns to ensure the generation of sufficient income to match future demands on our expanding services: Explore and develop new opportunities for potential income generation from Hospice activities. Continue to assess and maximize usage of space to generate income. Seek opportunities to introduce larger events with the potential to raise greater income through corporate growth. Strengthen and grow corporate supporters and support community fundraising activities. Maximise and review ecommerce activity. Develop public relations and communication strategy in line with the changing dynamics.

  2. Maintain a robust finance, investment and expenditure process: Develop a robust financial reporting system that will ensure the Hospice is ready for future tendering processes. Produce realistic budgets for all departments. Examine all sources of income increasing grant applications as a way of raising funds and analyse expenditure determining where savings can be made.

  3. Attract, develop, retain, support and reward our paid staff and volunteers to ensure a workforce fit to deliver Hospice goals: monitoring staffing levels and structure in line with changing needs and development. Develop a robust staff support system to ensure resilience of staff. Be consistent and effective with the support and development systems for all our people. Ensure Hospice values are reflected in our people process, carry out staff/volunteer satisfaction surveys then act on the relevant elements of the results to ensure staff feel supported and valued. Develop a staff reward process.

Page 13

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT) for the Year Ended 30 April 2021

STRUCTURE, GOVERNANCE & MANAGEMENT

GOVERNING DOCUMENT

The organisation is a charitable company limited by guarantee, incorporated on 16 September 1993, operating as Willow Wood Hospice. The Company was formed under a Memorandum of Association, which established the objects and powers of the charitable company and is governed under its Articles of Association.

The Company operates a subsidiary company trading known as Willow Wood Hospice Promotions Limited.

TRUSTEE COUNCIL OF MANAGEMENT

Members of the Council of Management, who are directors for the purpose of company law and Trustees for the purpose of charity law, who served during the year and up to the date of this report are shown on page 2. This report lists the Charity Trustees at the balance sheet date and those who had held office during the year; they are all members of the Council. The Company is a company limited by Guarantee with up to 30 members following a change at the AGM of November 2019. The Trustees are elected by the members at the Annual General Meeting to serve a term of three years. One third of the Trustees retire annually but may offer themselves for re-election by the members.

TRUSTEE RECRUITMENT, INDUCTION AND TRAINING

The board endeavours to ensure the make-up of its membership reflects the needs of the Hospice and the community it serves in providing a mix of professional skills necessary for the day-to-day and long term running of the Charity. The skills of our current panel of Trustees include clinicians, legal, architectural, human resourcesemployment Law, health and safety, communications and general professional management.

The organisational structure means the Board is responsible for the governance and strategic direction of Willow Wood. The day to day running of the Hospice is delegated to the Chief Executive and Senior Management within pre-defined levels of authority. The Chair and Vice Chair work closely with the Chief Executive and senior management team and Trustees are always on hand to bring their skills to assist with problem solving.

Board vacancies are identified through a skills audit by the Chair and board, a role description is formulated and the role is advertised in local media/social media. Newly selected and proposed Trustees are invited to interview and if selected, appointed on a 6-month probationary period. New Trustees are provided with an induction pack, which includes: role description, Hospice Code of Conduct, business plan, annual accounts, Memorandum of Articles, Annual Accounts and published guides on being a Hospice Trustee. Members of the council are expected to achieve 70% attendance in a financial year through either board or sub-committees.

In accordance with our general practice, meetings are held once every 12 weeks of the Council Trustees, the Chief Executive and members of the Senior Management team, attend these meetings. Individual reports from management ensuring all aspects of running the operations are covered. Council and Senior Management also set and agree the Hospice Strategic Plan.

In between Board meetings each trustee is allocated a seat/s at sub-group meetings which have specific terms of reference and functions including: finance & investment, volunteers, income generation and marketing, health & safety, clinical governance, clinical strategy, workforce planning and employee engagement forum, all of which encourage collaborative working amongst teams and ensures that all Hospice departments are working together as a well-informed unit. Each sub group is chaired by a trustee who has experience in that field. Working with the Chief Executive, Senior Managers and hospice staff, the purpose of the committee is for the Trustee to report back to board, make proposals and recommendations which in turn allows the monitoring and progress of objectives.

Willow Wood is a team-based operation. All personnel at Willow Wood must identify with our values, purpose and vision: to continue to be a leader in Hospice care, providing excellence in quality care to the people of Tameside and Glossop.

Page 14

TAMESIDE & GLOSSOP HOSPICE LIMITED

REPORT OF THE TRUSTEES (INCLUDING DIRECTORS’ REPORT AND STRATEGIC REPORT)

for the Year Ended 30 April 2021

RISK MANAGEMENT

The major risks to which the Charity is exposed as identified by the Trustees have been reviewed and strategies have been established to mitigate these risks. This involves identifying the types of risk the charity faces, prioritising them in terms of potential impact and likelihood of occurrence and identifying means of eliminating or mitigating the risks as appropriate. Risks are under continuous review and evaluation.

RESPONSIBILITIES OF THE COUNCIL OF MANAGEMENT

The Trustees, (who are also the directors of Tameside and Glossop Hospice Ltd for the purposes of company law) are responsible for preparing the Trustees’ Annual Report and the financial statements. These are prepared in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice) including FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland”.

Company law requires the Trustees to prepare financial statements for each financial year that give a true and fair view of the state of affairs of the charitable company as at the end of the financial year and of the surplus or deficit of the company for that period. In preparing those financial statements, the Trustees are required to:

The Trustees are responsible for maintaining proper accounting records that disclose with reasonable accuracy at any time the financial position of the company and to enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities

STATEMENT OF DISCLOSURE TO AUDITORS

In accordance with company law, as the company’s directors, we certify that:

On behalf of the Board of Trustees:

…………………………………………………………………. John H. Maltby LLB (Company Director/Trustee)

Date: 4[th] November 2022

Page 15

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF TAMESIDE & GLOSSOP HOSPICE LIMITED

Opinion

We have audited the financial statements of Tameside & Glossop Hospice Limited (the 'parent charitable company') and its subsidiary (‘the group’) for the year ended 30 April 2022 which comprise the consolidated Statement of Financial Activities, the consolidated Balance Sheet, the Company Balance Sheet, the consolidated Cash Flow Statement and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

Other information

The trustees are responsible for the other information. The other information comprises the information included in the Annual Report, other than the financial statements and our Report of the Independent Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

Page 16

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF TAMESIDE & GLOSSOP HOSPICE LIMITED

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the group and the charitable parent company and its environment obtained in the course of the audit, we have not identified material misstatements in the Report of the Trustees.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of trustees

As explained more fully in the Statement of Trustees' Responsibilities, the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the trustees are responsible for assessing the charitable company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

Our responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Independent Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Enquiries were made of the Trustees and management with a view to identifying those laws and regulations that could be expected to have a material impact on the financial statements.

We obtained an understanding of the legal and regulatory framework that the company operates in, and the principal risks of non-compliance with laws and regulations which we identified as being significant to the company related to UK Financial Reporting Standards, Company Law, Charity Law, UK Tax Legislation and Health & Safety regulations. We considered the extent to which the non-compliance with these regulations would have an impact on the accounts.

The audit procedures we undertook in response to the potential risks relating to irregularities (which include fraud and non-compliance with laws and regulations) included, but not limited to:

Page 17

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF TAMESIDE & GLOSSOP HOSPICE LIMITED

Bec ause of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Independent Auditors.

Use of our report

This report is made solely to the charitable company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company's members those matters we are required to state to them in an auditors' report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company's members as a body, for our audit work, for this report, or for the opinions we have formed.

David Evans FCA (Senior Statutory Auditor) for and on behalf of Moss & Williamson Limited Chartered Accountants Statutory Auditor Booth Street Chambers Ashton-under-Lyne Lancashire OL6 7LQ

Date: 4 November 2022

Page 18

TAMESIDE & GLOSSOP HOSPICE LIMITED

CONSOLIDATED STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING AN INCOME AND EXPENDITURE ACCOUNT) for the Year Ended 30 April 2022

Notes
INCOME AND ENDOWMENTS FROM
Donations and legacies
2
Other trading activities
3
Investment income
4
Other income
Total
EXPENDITURE ON
Raising funds
Raising donations and legacies
5
Charitable activities
6
Hospice
Fundraising
Governance
Lottery
Trading expenses
Total
Net gains/(losses) on investments
NET INCOME
RECONCILIATION OF FUNDS
Total funds brought forward
TOTAL FUNDS CARRIED FORWARD		 Unrestricted
funds
£
1,826,741
1,581,391
173,495
216,595
3,798,222
269,538
269,538
2,149,603
46,068
35,337
199,004
779,095
3,478,645
(151,396)
168,181
6,483,107
6,651,288		 Restricted
fund
£
384,282
-
-
-
384,282
-
-
338,149
-
-
-
-
338,149
-
46,133
210,451
**256,584 **		 2022
Total
funds
£
2,211,023
1,581,391
173,495
216,595
4,182,504
269,538
269,538
2,487,752
46,068
35,337
199,004
779,095
3,816,794
(151,396)
214,314
6,693,558
6,907,872		 2021
Total
funds
£
2,243,168
1,131,284
174,375
437,437
3,986,264
194,904
194,904
2,308,246
34,790
32,886
173,773
617,939
3,362,538
319,858
943,584
5,749,974
6,693,558

The notes form part of these financial statements

Page 19

TAMESIDE & GLOSSOP HOSPICE LIMITED

CONSOLIDATED BALANCE SHEET 30 April 2022

Notes
FIXED ASSETS
Tangible assets
13
Investments
Investments
14
Investment property
15
CURRENT ASSETS
Stocks
16
Debtors
17
Cash at bank and in hand
CREDITORS
Amounts falling due within one year
18
NET CURRENT ASSETS
TOTAL ASSETS LESS CURRENT
LIABILITIES
NET ASSETS
FUNDS
20
Unrestricted funds:
General fund
Designated
Restricted funds:
Restricted
TOTAL FUNDS		 Unrestricted
Restricted
funds
fund

£
£
2,600,509
22,875
3,105,342
233,709
215,000
-
5,920,851
256,584
16,955
-
533,001
-
576,701
-
1,126,657
-
(396,220)
-
730,437
-
6,651,288
256,584
6,651,288
**256,584 **		 2022

Total
funds
£
2,623,384
3,339,051
215,000
6,177,435
16,955
533,001
576,701
1,126,657
(396,220)
730,437
6,907,872
6,907,872
4,151,307
2,499,981
6,651,288
256,584
6,907,872		 2021
Total
funds
£
2,702,578
3,292,454
215,000
6,210,032
21,373
446,557
382,753
850,683
(367,157)
483,526
6,693,558
6,693,558
3,934,001
2,549,106
6,483,107
210,451
6,693,558

The financial statements were approved by the Board of Trustees and authorised for issue on 4 November 2022 and were signed on its behalf by:

............................................. Trustee

The notes form part of these financial statements

Page 20

TAMESIDE & GLOSSOP HOSPICE LIMITED

COMPANY BALANCE SHEET 30 April 2022

Notes
FIXED ASSETS
Tangible assets
13
Investments
Investments
14
Investment property
15
CURRENT ASSETS
Stocks
16
Debtors
17
Cash at bank and in hand
CREDITORS
Amounts falling due within one year
18
NET CURRENT ASSETS
TOTAL ASSETS LESS CURRENT
LIABILITIES
NET ASSETS
FUNDS
20
Unrestricted funds:
General fund
Designated
Restricted funds:
Restricted
TOTAL FUNDS		 Unrestricted
Restricted
funds
fund

£
£
2,590,449
22,875
3,105,352
233,709
215,000
-
5,910,801
256,584
16,955
-
981,910
-
19,900
-
1,018,765
-
(278,854)
-
739,911
-
6,650,712
256,584
6,650,712
**256,584 **		 2022

Total
funds
£
2,613,324
3,339,061
215,000
6,167,385
16,955
981,910
19,900
1,018,765
(278,854)
739,911
6,907,296
6,907,296
4,150,731
2,499,981
6,650,712
256,584
6,907,296		 2021
Total
funds
£
2,431,619
3,292,464
215,000
5,939,083
21,373
932,132
67,343
1,020,848
(266,949)
753,899
6,692,982
6,692,982
3,933,425
2,549,106
6,482,531
210,451
6,692,982

The financial statements were approved by the Board of Trustees and authorised for issue on 4 November 2022 and were signed on its behalf by:

............................................. Trustee

The notes form part of these financial statements

Page 21

TAMESIDE & GLOSSOP HOSPICE LIMITED

CONSOLIDATED CASH FLOW STATEMENT for the Year Ended 30 April 2022

Notes
Cash flows from operating activities
Cash generated from operations
1
Net cash provided by operating activities
Cash flows from investing activities
Purchase of tangible fixed assets
Purchase of fixed asset investments
Sale of tangible fixed assets
Sale of fixed asset investments
Dividends received
Net cash used in investing activities
Change in cash and cash equivalents
in the reporting period
Cash and cash equivalents at the
beginning of the reporting period
Cash and cash equivalents at the end
of the reporting period		 2022
£
312,114
312,114
(24,950)
(345,612)
-
147,619
104,777
(118,166)
193,948
382,753
**576,701 **		 2021
£
528,380
528,380
(6,843)
(892,310)
6,868
395,010
93,103
(404,172)
124,208
258,545
382,753

The notes form part of these financial statements

Page 22

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE CONSOLIDATED CASH FLOW STATEMENT for the Year Ended 30 April 2022

1. RECONCILIATION OF NET INCOME TO NET CASH FLOW FROM OPERATING ACTIVITIES RECONCILIATION OF NET INCOME TO NET CASH FLOW FROM OPERATING ACTIVITIES RECONCILIATION OF NET INCOME TO NET CASH FLOW FROM OPERATING ACTIVITIES RECONCILIATION OF NET INCOME TO NET CASH FLOW FROM OPERATING ACTIVITIES RECONCILIATION OF NET INCOME TO NET CASH FLOW FROM OPERATING ACTIVITIES
2022 2021
£ £
Net income for the reporting period (as per the Statement of
Financial Activities) 214,314 943,584
Adjustments for:
Depreciation charges 104,144 114,318
Losses/(gain) on investments 151,396 (319,858)
Profit on disposal of fixed assets - (6,868)
Dividends received (104,777) (93,103)
Decrease/(increase) in stocks 4,418 (9,578)
Increase in debtors (86,444) (71,204)
Increase/(decrease) in creditors 29,063 (28,911)
Net cash provided by operations 312,114 528,380
2. ANALYSIS OF CHANGES IN NET FUNDS
At 1.5.21 Cash flow At 30.4.22
£ £ £
Net cash
Cash at bank and in hand 382,753 193,948 **576,701 **
382,753 193,948 **576,701 **
Total 382,753 193,948 **576,701 **

The notes form part of these financial statements

Page 23

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS for the Year Ended 30 April 2022

1. ACCOUNTING POLICIES

Basis of preparing the financial statements

The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention, with the exception of investments which are included at market value, as modified by the revaluation of certain assets.

The presentation currency of the financial statements is the pound Sterling (£).

Income

All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.

Expenditure

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.

Allocation and apportionment of costs

Fund-raising costs are those incurred in seeking voluntary contributions including marketing and advertising but do not include the costs of disseminating information in support of charitable activities.

Governance costs are those incurred in connection with governance of the charity and are associated with constitutional and statutory requirements and strategic non day-to-day management of the charity's activities.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Freehold property - 2% on cost
Long leasehold - 2% on cost
Plant and machinery - 20% on cost
Computer equipment - 33% on cost

Investment property

Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in the Statement of Financial Activities.

Stocks

Bought in stocks are valued at the lower of cost or net realisable value after making due allowance for obsolete or slow moving items. Unsold donated items are not included in closing stock because of the uncertainty and impracticality of valuation.

Taxation

The charity is exempt from corporation tax on its charitable activities.

Page 24

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2022

1. ACCOUNTING POLICIES - continued

Fund accounting

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.

Designated Funds are unrestricted funds with the specific purpose of funding the building and development of Willow Wood Hospice and includes £100,000 as a Support Grant (enhanced by interest generated on the funds specifically invested for these purposes) and £497,000 as an Asset Replacement Provision. In addition, several years ago the Hospice received two grants from the PCT totalling £936,118 which the Trustees allocated for the building extension and extensive Hospice refurbishment programme that was undertaken. The net balance of these grants continue to be held by the Trustees against future refurbishment costs and continue to be enhanced by interest generated on funds invested for this purpose. Two further grants of £60,000 were received during 2012 from the PCT and the Trustees have designated these for future Hospice development. Again, these are enhanced by interest generated on the funds invested for this purpose. At the balance sheet date, the Designated Funds invested for future Hospice development stands at £953,188 (2021: £947,732). The remainder of the Designated funds have already been spent by the Trustees and are within the Accounts as Long Leasehold Property £1,546,793 (2021 - £1,598,768) and Plant & Machinery £Nil (2021 - £2,606).

Pension costs and other post-retirement benefits

For those people for whom pension contributions are made the company pays into the NHS final salary (defined benefit) pension scheme and a separate Stakeholder (money purchase) pension scheme. The company also pays into an auto enrolment pension scheme. Contributions payable to all these schemes are charged to the profit and loss account in the period to which they relate. These contributions are invested separately from the company’s assets.

Voluntary help and gifts in kind

No value has been placed on the help received by Tameside & Glossop Hospice Limited during the year. The charity receives a number of non-cash donations, it is not practicable for these gifts in kind to be recognised and valued when received. Income is accounted for in the accounting period in which the gift is sold. There were no individual gifts of significant value.

2. DONATIONS AND LEGACIES

Grants
Individuals
Companies
99ers Club
Trusts
In Memoriam
Gift aid shop sales
Gift Aid/G.A.Y.E.
Collecting cans
Deed of covenant
Legacies
Death certificates
Members' subscriptions		 2022
£
868,206
67,178
45,892
3,394
131,275
156,271
138,673
74,196
17,090
12,313
686,339
9,676
520
2,211,023		 2021
£
1,214,891
207,314
23,524
4,100
62,809
139,000
24,007
75,336
9,450
10,903
462,232
9,102
500
2,243,168

Page 25

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2022

2. DONATIONS AND LEGACIES - continued

Grants received, included in the above, are as follows:

Other grants
3.
OTHER TRADING ACTIVITIES
Shop income
Lottery income
Superdraw income
External Fundraising
Internal Fundraising
Sale of promotional items
Calendars & Christmas cards
Seasonal promotions
Appeal income
Coffee mornings
Light up a Life
Midnight Wander
Hospice ball
Sahara Trek
Butterfly Release
Bubble Rush
Back to the Fitness
Golf day
Bunny hop
Memory stone
Direct mail campaign
Strictly Come Dancing
4.
INVESTMENT INCOME
Rent received
Interest on Investments
Dividends received
Profit-disposal of investments		 2022
£
868,206
2022
£
813,921
535,968
42,726
64,781
21,509
6,074
(4,257)
88
3,578
1,340
5,810
27,668
1,908
(6,939)
3,329
-
-
3,949
38,473
2,794
6,304
12,367
1,581,391
2022
£
68,571
147
34,011
70,766
173,495		 2021
£
1,214,891
2021
£
413,686
529,535
67,127
50,635
4,732
6,729
(5,011)
862
1,573
2,820
11,039
6,512
-
-
10,925
(3,692)
116
3,034
19,055
2,129
9,478
-
1,131,284
2021
£
80,850
422
33,162
59,941
174,375

Page 26

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2022

5.
RAISING DONATIONS AND LEGACIES
Staff costs
Fundraising costs
6.
CHARITABLE ACTIVITIES COSTS
Hospice
Fundraising
Governance
Lottery
Trading expenses
7.
DIRECT COSTS OF CHARITABLE ACTIVITIES
Staff costs
Therapy costs & consumables
Support costs
Stationery
Catering supplies
Medical supplies
Training expenses
Laundry & cleaning
Waste disposal
Depreciation
Repairs & maintenance
Rental property expenditure
Sundry equipment
Website costs
Travel & minibus
Criminal record checking
Recruitment
Trading expenses of subsidiary
Lottery prizes
Superdraw prizes
Lottery administration costs		 Direct
Costs (see
note 7)
£
2,060,393
11,426
-
199,004
779,095
3,049,918

Page 27

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2022

8. SUPPORT COSTS

Management
£
Hospice
419,418
Fundraising
33,375
Governance
-
452,793		 Governance
Finance
costs
£
£
7,941
-
1,267
-
-
35,337
9,208
**35,337 **		 Totals
£
427,359
34,642
35,337
497,338

Support costs, included in the above, are as follows:

Management

Salaries, NI & pensions
Rates and water
Insurance
Heat & light
Communications
Postage
Computer support costs
Sundry expenses
Subscription/registration fees
Portfolio management fees
Depreciation of tangible assets
Finance
Bank charges		 Hospice
Fundraising
£
£
258,583
19,463
13,317
1,002
21,080
1,587
28,163
2,120
6,534
492
2,783
271
47,775
4,112
15,130
2,142
3,579
494
15,977
1,203
6,497
489
419,418
33,375
Hospice
Fundraising
£
£
7,941
**1,267 **		 2022
2021
Total
Total
activities
activities
£
£
278,046
263,845
14,319
13,049
22,667
15,197
30,283
29,255
7,026
3,754
3,054
2,641
51,887
48,650
17,272
14,774
4,073
3,798
17,180
15,295
6,986
9,903
452,793
420,161
2022
2021
Total
Total
activities
activities
£
£
9,208
8,947

Page 28

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2022

8. SUPPORT COSTS - continued

Governance costs

Legal & professional fees
Audit & Accountancy		 2022
£
26,687
8,650
**35,337 **		 2021
£
25,446
7,440
32,886

9. NET INCOME/(EXPENDITURE)

Net income/(expenditure) is stated after charging/(crediting):

2022 2021
£ £
Depreciation - owned assets 104,144 114,318
Surplus on disposal of fixed assets - (6,868)
Auditors remuneration 8,650 7,440

10. TRUSTEES' REMUNERATION AND BENEFITS

There were no trustees' remuneration or other benefits for the year ended 30 April 2022 nor for the year ended 30 April 2021.

Trustees' expenses

There were no trustees' expenses paid for the year ended 30 April 2022 nor for the year ended 30 April 2021.

11. STAFF COSTS

Wages and salaries
Social Security costs
Pension costs		 2022
£
2,505,287
204,618
111,658
2,821,563		 2021
£
2,210,174
182,611
114,251
2,507,036

The average monthly number of employees during the year was as follows:

Employees 2022
99		 2021
94

Page 29

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2022

11. STAFF COSTS - continued

The number of employees whose employee benefits (excluding employer pension costs) exceeded £60,000 was:

£70,001 - £80,000
12.
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
Unrestricted
funds
£
INCOME AND ENDOWMENTS FROM
Donations and legacies
1,583,017
Other trading activities
1,131,284
Investment income
174,375
Other income
437,437
Total
3,326,113
EXPENDITURE ON
Raising funds
Raising donations and legacies
194,904
194,904
Charitable activities
Hospice
1,620,253
Fundraising
34,790
Governance
32,886
Lottery
173,773
Trading expenses
617,939
Total
2,674,545
Net gains on investments
319,858
NET INCOME/(EXPENDITURE)
971,426
RECONCILIATION OF FUNDS
Total funds brought forward
5,511,681
TOTAL FUNDS CARRIED FORWARD
6,483,107		 2022
1
Restricted
fund
£
660,151
-
-
-
660,151
-
-
687,993
-
-
-
-
687,993
-
(27,842)
238,293
210,451		 2021
1
Total
funds
£
2,243,168
1,131,284
174,375
437,437
3,986,264
194,904
194,904
2,308,246
34,790
32,886
173,773
617,939
3,362,538
319,858
943,584
5,749,974
6,693,558

Page 30

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2022

13. TANGIBLE FIXED ASSETS

GROUP

COST
At 1 May 2021
Additions
At 30 April 2022
DEPRECIATION
At 1 May 2021
Charge for year
At 30 April 2022
NET BOOK VALUE
At 30 April 2022
At 30 April 2021
COST
At 1 May 2021
Additions
At 30 April 2022
DEPRECIATION
At 1 May 2021
Charge for year
At 30 April 2022
NET BOOK VALUE
At 30 April 2022
At 30 April 2021		 Plant and
machinery
£
389,524
15,587
405,111
359,360
19,202
378,562
26,549
30,164		 Freehold
property
£
669,557
-
669,557
122,366
13,394
135,760
533,797
547,191
Motor
vehicles
£
63,970
-
63,970
63,970
-
63,970
-
-		 Improvements
Long
to
leasehold
property
£
£
3,204,810
-
-
9,364
3,204,810
9,364
1,091,412
-
64,093
468
1,155,505
468
2,049,305
8,896
2,113,398
-
Computer
equipment
Totals
£
£
67,729
4,395,590
-
24,951
67,729
4,420,541
55,904
1,693,012
6,988
104,145
62,892
1,797,157
4,837
2,623,384
11,825
2,702,578

Page 31

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2022

13. TANGIBLE FIXED ASSETS - continued

COMPANY

COST
At 1 May 2021
Additions
At 30 April 2022
DEPRECIATION
At 1 May 2021
Charge for year
At 30 April 2022
NET BOOK VALUE
At 30 April 2022
At 30 April 2021
COST
At 1 May 2021
Additions
At 30 April 2022
DEPRECIATION
At 1 May 2021
Charge for year
At 30 April 2022
NET BOOK VALUE
At 30 April 2022
At 30 April 2021		 Freehold
property
£
669,557
-
669,557
122,366
13,394
135,760
533,797
547,191
Motor
vehicles
£
63,970
-
63,970
63,970
-
63,970
-
-		 Long
leasehold
£
2,873,855
260,439
3,134,294
1,027,511
57,478
1,084,989
2,049,305
1,846,344
Computer
equipment
£
67,729
-
67,729
55,904
6,988
62,892
4,837
11,825		 Plant and
machinery
£
351,017
15,587
366,604
324,758
16,461
341,219
25,385
26,259
Totals
£
4,026,128
276,026
4,302,154
1,594,509
94,321
1,688,830
2,613,324
2,431,619

Page 32

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2022

14. FIXED ASSET INVESTMENTS

GROUP

MARKET VALUE
At 1 May 2021
Additions
Disposals
Unrealised gain
At 30 April 2022
NET BOOK VALUE
At 30 April 2022
At 30 April 2021
COMPANY
MARKET VALUE
At 1 May 2021
Additions
Disposals
Revaluations
At 30 April 2022
NET BOOK VALUE
At 30 April 2022
At 30 April 2021		 Shares in
group
undertakings
£
10
-
-
-
10
10
10		 Listed
investments
£
1,984,986
230,971
(147,619)
(151,396)
1,916,942
1,916,942
1,984,986
Listed

investments
£
1,984,986
230,971
(147,619)
(151,396)
1,916,942
1,916,942
1,984,986		 Notice &
Term bank
accounts
£
1,307,468
114,641
-
-
1,422,109
1,422,109
1,307,468
Notice &
Term bank
accounts
£
1,307,468
114,641
-
-
1,422,109
1,422,109
1,307,468		 Totals
£
3,292,454
345,612
(147,619)
(151,396)
3,339,051
3,339,051
3,292,454
Totals
£
3,292,464
345,612
(147,619)
(151,396)
3,339,061
3,339,061
3,292,464

There were no investment assets outside the UK. Listed investments are reported at market value as at 30 April 2022.

Cost or valuation at 30 April 2022 is represented by:

Valuation in 2022
Cost		 Shares in
group
Listed
undertakings investments
£
£
-
1,916,942
10
-
10
1,916,942		 Notice &
Term bank

accounts
£
-
1,422,109
1,422,109		 Totals
£
1,916,942
1,422,119
**3,339,061 **

Page 33

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2022

14. FIXED ASSET INVESTMENTS

The company's investments at the balance sheet date in the share capital of companies include the following:

Willow Wood Hospice Promotions Limited

Registered office: Willow Wood Close, Mellor Road, Ashton-under-Lyne, Lancashire Nature of business: Running charity shops and lottery.

%
Class of share:
holding
Ordinary
100
2022
£
Aggregate capital and reserves
586
15.
INVESTMENT PROPERTY
FAIR VALUE
At 1 May 2021
and 30 April 2022
NET BOOK VALUE
At 30 April 2022
At 30 April 2021		 2021
£
586
£
215,000
215,000
215,000

The Investment Properties were acquired as part of two legacies left to the Hospice. Both are Residential Properties and the Trustees made the decision to let the properties out to generate on going funds for the Hospice.

16.
STOCKS
Stocks
Stocks consist of items acquired for medical and fundraising purposes.
17.
DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
GROUP
Debtors & prepayments
Other debtors
VAT
COMPANY
Debtors & prepayments
Amounts owed by group undertakings
Other debtors
VAT		 2022
£
16,955
2022
£
52,523
461,485
18,993
533,001
2022
£
52,523
487,994
422,400
18,993
981,910		 2021
£
21,373
2021
£
51,319
371,187
24,051		 2021
£
21,373
446,557
2021
£
51,319
565,432
291,801
23,580
932,132

Page 34

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2022

18. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

GROUP

Trade creditors
Social security and other taxes
Other creditors
Grants received in advance
Accruals & deferred income
COMPANY
Trade creditors
Social security and other taxes
Other creditors
Grants received in advance
Accruals & deferred income		 2022
£
70,870
79,759
106,142
112,162
27,287
396,220
2022
£
33,095
79,759
26,551
112,162
27,287
**278,854 **		 2021
£
39,973
82,826
110,876
111,415
22,067
367,157
2021
£
25,598
81,105
26,764
111,415
22,067
266,949

19. LEASING AGREEMENTS

GROUP

Minimum lease payments under non-cancellable operating leases fall due as follows:

Within one year
Between one and five years
In more than five years		 2022
£
5,878
69,886
82,504
158,268		 2021
£
3,437
160,314
78,083
241,834

COMPANY

Minimum lease payments under non-cancellable operating leases fall due as follows:

Within one year
Between one and five years
In more than five years		 2022
£
2,521
3,470
35,704
41,695		 2021
£
-
12,969
11,500
24,469

Page 35

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2022

20. MOVEMENT IN FUNDS

GROUP

Unrestricted funds
General fund
Designated
Restricted funds
Restricted
TOTAL FUNDS		 At 1.5.21
£
3,934,001
2,549,106
6,483,107
210,451
6,693,558		 Net
movement
in funds
£
222,306
(54,125)
168,181
46,133
214,314		 Transfers
between
funds
£
(5,000)
5,000
-
-
-		 At
30.4.22
£
4,151,307
2,499,981
6,651,288
256,584
6,907,872

Net movement in funds, included in the above are as follows:

Unrestricted funds
General fund
Designated
Restricted funds
Restricted
TOTAL FUNDS		 Incoming
resources
£
3,797,766
456
3,798,222
384,282
**4,182,504 **		 Resources
expended
£
(3,424,064)
(54,581)
(3,478,645)
(338,149)
(3,816,794)		 Gains and
losses
£
(151,396)
-
(151,396)
-
**(151,396) **		 Movement
in funds
£
222,306
(54,125)
168,181
46,133
214,314

Page 36

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2022

20. MOVEMENT IN FUNDS - continued

Comparatives for movement in funds

Unrestricted funds
General fund
Designated
Restricted funds
Restricted
TOTAL FUNDS		 At 1.5.20
£
2,912,334
2,599,347
5,511,681
238,293
5,749,974		 Net
movement
in funds
£
1,026,667
(55,241)
971,426
(27,842)
943,584		 Transfers
between
funds
£
(5,000)
5,000
-
-
-		 At
30.4.21
£
3,934,001
2,549,106
6,483,107
210,451
6,693,558

Comparative net movement in funds, included in the above are as follows:

Unrestricted funds
General fund
Designated
Restricted funds
Restricted
TOTAL FUNDS		 Incoming
resources
£
3,325,659
454
3,326,113
660,151
3,986,264		 Resources
expended
£
(2,618,850)
(55,695)
(2,674,545)
(687,993)
(3,362,538)		 Gains and
losses
£
319,858
-
319,858
-
319,858		 Movement
in funds
£
1,026,667
(55,241)
971,426
(27,842)
943,584

A current year 12 months and prior year 12 months combined position is as follows:

Unrestricted funds
General fund
Designated
Restricted funds
Restricted
TOTAL FUNDS		 At 1.5.20
£
2,912,334
2,599,347
5,511,681
238,293
5,749,974		 Net
movement
in funds
£
1,248,973
(109,366)
1,139,607
18,291
1,157,898		 Transfers
between
funds
£
(10,000)
10,000
-
-
-		 At
30.4.22
£
4,151,307
2,499,981
6,651,288
256,584
6,907,872

Page 37

continued...

TAMESIDE & GLOSSOP HOSPICE LIMITED

NOTES TO THE FINANCIAL STATEMENTS - continued for the Year Ended 30 April 2022

20. MOVEMENT IN FUNDS - continued

A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows:

Unrestricted funds
General fund
Designated
Restricted funds
Restricted
TOTAL FUNDS		 Incoming
resources
£
7,123,425
910
7,124,335
1,044,433
8,168,768		 Resources
expended
£
(6,042,914)
(110,276)
(6,153,190)
(1,026,142)
(7,179,332)		 Gains and
losses
£
168,462
-
168,462
-
168,462		 Movement
in funds
£
1,248,973
(109,366)
1,139,607
18,291
1,157,898

21. EMPLOYEE BENEFIT OBLIGATIONS

The Charity operates two pension schemes for staff and these are outlined below:

National Health Service Superannuation Scheme

The group is an admitted body for the purposes of the National Health Service Superannuation Scheme. Due to the nature of the scheme there are no separately identifiable assets or liabilities which can be identified as relating to the Hospice. Therefore the scheme has been accounted for as a defined contribution scheme.

The amount of contributions recognised in the statement of financial activity as an expense is £89,290

(2021: £97,458).

Stakeholder Pension Scheme

The group supports a Stakeholder Pension Auto-enrolment scheme operated by Standard Life. Employee contributions are collected by the Hospice and matching employer's contributions are passed on to Standard Life. All the assets and liabilities are held by Standard Life and there are no separately identifiable assets or liabilities which can be identified as relating to the Hospice. Therefore the scheme has been accounted for as a defined contribution scheme.

The amount of contributions recognised in the statement of financial activity as an expense is £65,003 ((2021: £57,857).

22. RELATED PARTY DISCLOSURES

There were no related party transactions for the year ended 30 April 2022.

23. INDIVIDUAL STATEMENT OF FINANCIAL ACTIVITY

As permitted by Section 408 of the Companies Act 2006, the Statement of Financial Activity of the parent Charity is not presented as part of these financial statements.

Page 38

TAMESIDE & GLOSSOP HOSPICE LIMITED

DETAILED STATEMENT OF FINANCIAL ACTIVITIES for the Year Ended 30 April 2022

INCOME AND ENDOWMENTS
Donations and legacies
Grants
Individuals
Companies
99ers Club
Trusts
In Memoriam
Gift aid shop sales
Gift Aid/G.A.Y.E.
Collecting cans
Deed of covenant
Legacies
Death certificates
Members' subscriptions
Other trading activities
Shop income
Lottery income
Superdraw income
External Fundraising
Internal Fundraising
Sale of promotional items
Calendars & Christmas cards
Seasonal promotions
Appeal income
Coffee mornings
Light up a Life
Midnight Wander
Hospice ball
Sahara Trek
Butterfly Release
Bubble Rush
Back to the Fitness
Golf day
Bunny hop
Memory stone
Direct mail campaign
Strictly Come Dancing
Investment income
Rent received
Interest on Investments
Dividends received
Carried forward		 2022
£
868,206
67,178
45,892
3,394
131,275
156,271
138,673
74,196
17,090
12,313
686,339
9,676
520
2,211,023
813,921
535,968
42,726
64,781
21,509
6,074
(4,257)
88
3,578
1,340
5,810
27,668
1,908
(6,939)
3,329
-
-
3,949
38,473
2,794
6,304
12,367
1,581,391
68,571
147
34,011
102,729		 2021
£
1,214,891
207,314
23,524
4,100
62,809
139,000
24,007
75,336
9,450
10,903
462,232
9,102
500
2,243,168
413,686
529,535
67,127
50,635
4,732
6,729
(5,011)
862
1,573
2,820
11,039
6,512
-
-
10,925
(3,692)
116
3,034
19,055
2,129
9,478
-
1,131,284
80,850
422
33,162
114,434

This page does not form part of the statutory financial statements

Page 39

TAMESIDE & GLOSSOP HOSPICE LIMITED

DETAILED STATEMENT OF FINANCIAL ACTIVITIES
for the Year Ended 30 April 2022
2022
£
Investment income
Brought forward
102,729
Profit-disposal of investments
70,766
173,495
Other income
Gain on sale of tangible fixed assets
-
Other income
216,595
216,595
Total incoming resources
4,182,504
EXPENDITURE
Raising donations and legacies
Staff costs
259,054
Fundraising costs
10,484
269,538
Charitable activities
Staff costs
1,765,982
Pensions
1
Therapy costs & consumables
1,265
Support costs
44,747
Stationery
6,159
Catering supplies
36,021
Medical supplies
22,292
Training expenses
3,975
Laundry & cleaning
15,855
Waste disposal
7,518
Depreciation
87,330
Repairs & maintenance
39,414
Rental property expenditure
18,435
Sundry equipment
1,727
Website costs
8,630
Travel & minibus
8,643
Criminal record checking
1,422
Recruitment
2,403
Trading expenses of subsidiary
779,095
Lottery prizes
75,765
Superdraw prizes
7,500
Lottery administration costs
115,739
3,049,918
Support costs
Management
Salaries, NI & pensions
278,046
Carried forward
278,046		 2021
£
114,434
59,941
174,375
6,868
430,569
437,437
3,986,264
189,651
5,253
194,904
1,649,415
-
1,165
38,334
4,162
22,762
28,922
12,188
14,245
7,477
91,765
27,815
5,155
404
1,768
6,740
586
1,025
617,939
76,653
7,500
89,620
2,705,640
263,845
263,845

This page does not form part of the statutory financial statements

Page 40

TAMESIDE & GLOSSOP HOSPICE LIMITED

DETAILED STATEMENT OF FINANCIAL ACTIVITIES for the Year Ended 30 April 2022

Management
Brought forward
Rates and water
Insurance
Heat & light
Communications
Postage
Computer support costs
Sundry expenses
Subscription/registration fees
Portfolio management fees
Depreciation of tangible and heritage
assets
Finance
Bank charges
Governance costs
Legal & professional fees
Audit & Accountancy
Total resources expended
Net income		 2022
£
278,046
14,319
22,667
30,283
7,026
3,054
51,887
17,272
4,073
17,180
6,986
452,793
9,208
26,687
8,650
35,337
3,816,794
365,710		 2021
£
263,845
13,049
15,197
29,255
3,754
2,641
48,650
14,774
3,798
15,295
9,903
420,161
8,947
25,446
7,440
32,886
3,362,538
623,726

This page does not form part of the statutory financial statements

Page 41